EDGAR Filing Documents for 0001213900-23-050508

Form 8-K - Current report:

SEC Accession No. 0001213900-23-050508

Filing Date

2023-06-21

Accepted

2023-06-21 16:16:24

Documents

Period of Report

2023-06-18

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea180640-8k_virpaxpharm.htm iXBRL	8-K	40000
2	EMPLOYMENT AGREEMENT, DATED JUNE 20, 2023, BY AND BETWEEN VIRPAX PHARMACEUTICALS	ea180640ex10-1_virpax.htm	EX-10.1	80832
3	SEPARATION AGREEMENT, DATED JUNE 18, 2023 BY AND BETWEEN VIRPAX PHARMACEUTICALS,	ea180640ex10-2_virpax.htm	EX-10.2	112912
4	PRESS RELEASE, ISSUED BY VIRPAX PHARMACEUTICALS, INC. DATED JUNE 20, 2023	ea180640ex99-1_virpax.htm	EX-99.1	9550
5	GRAPHIC	ex99-1_001.jpg	GRAPHIC	2465
	Complete submission text file	0001213900-23-050508.txt		484600

Data Files

Seq	Description	Document	Type	Size
6	XBRL SCHEMA FILE	vrpx-20230618.xsd	EX-101.SCH	2971
7	XBRL LABEL FILE	vrpx-20230618_lab.xml	EX-101.LAB	34240
8	XBRL PRESENTATION FILE	vrpx-20230618_pre.xml	EX-101.PRE	22367
10	EXTRACTED XBRL INSTANCE DOCUMENT	ea180640-8k_virpaxpharm_htm.xml	XML	3720

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312

Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597

Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)